Difference between revisions of "Team:Stony Brook/Human Practices"

(Prototype team page)
 
 
(43 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Stony_Brook}}
+
{{Stony_Brook TryingFailing}}
 
<html>
 
<html>
 +
  
 
<div class="column full_size">
 
<div class="column full_size">
 
+
<div align="center">
<p>iGEM teams are leading in the area of Human Practices because they conduct their projects within a social/environmental context, to better understand issues that might influence the design and use of their technologies.</p>
+
<h1> Human Practices </h1>
<p>Teams work with students and advisors from the humanities and social sciences to explore topics concerning ethical, legal, social, economic, safety or security issues related to their work. Consideration of these Human Practices is crucial for building safe and sustainable projects that serve the public interest. </p>
+
<br>
<p>For more information, please see the <a href="https://2016.igem.org/Human_Practices">Human Practices Hub</a>.</p>
+
<hr>
 +
</div>
 
</div>
 
</div>
  
 +
<div class="column full_size">
 +
<div align="center">
  
<div class="column half_size">
+
<h2> Insight on the application of a blood test using the GPC1 detection system </h2>
<div class="highlight">
+
<br>
<h5>Note</h5>
+
<p> iGEM team members met with an internal medicine specialist, Bibi Zainul, MD., and discussed our project idea as well as applications, should our project succeed. We spoke about the viability of using our yeast as a non-invasive detection tool by performing periodic blood tests on patients who are more susceptible to pancreatic cancer. She made us aware that the tools we require to perform such a test, like a centrifuge and UV lights, are not typically available in most private practice offices and only in some hospitals. She also offered us advice on how to move forward and led us to redesign the application of our project. Due to this, we decided that it would be best to use our project as a lab test that a doctor could order and could be performed off-premises. This affects our project in the following ways: </p>
<p>You must fill out this page in order to be considered for all <a href="https://2016.igem.org/Judging/Awards">awards</a> for Human Practices:</p>
+
 
<ul>
 
<ul>
<li>Human Practices silver medal criterion</li>
+
<li> Despite going through an intermediate service, reproducible yeast should still be a cheap alternative to current methods of early detection. </li>
<li>Human Practices gold medal criterion</li>
+
<li> We would have to optimize our test to make it more friendly to a hospital environment if we were to try to make it a test that could be done in the hospital. </li>
<li>Best Integrated Human Practices award</li>
+
<li>Best Education and Public Engagement award</li>
+
 
</ul>
 
</ul>
 
</div>
 
</div>
 
</div>
 
</div>
 
<div class="column half_size">
 
<h5>Some Human Practices topic areas </h5>
 
<ul>
 
<li>Philosophy</li>
 
<li>Public Engagement / Dialogue</li>
 
<li>Education</li>
 
<li>Product Design</li>
 
<li>Scale-Up and Deployment Issues</li>
 
<li>Environmental Impact</li>
 
<li>Ethics</li>
 
<li>Safety</li>
 
<li>Security</li>
 
<li>Public Policy</li>
 
<li>Law and Regulation</li>
 
<li>Risk Assessment</li>
 
</ul>
 
</div>
 
 
 
<div class="column half_size">
 
<h5>What should we write about on this page?</h5>
 
<p>On this page, you should write about the Human Practices topics you considered in your project, and document any special activities you did (such as visiting experts, talking to lawmakers, or doing public engagement).</p>
 
</div>
 
 
 
<div class="column half_size">
 
<h5>Inspiration</h5>
 
<p>Read what other teams have done:</p>
 
<ul>
 
<li><a href="https://2014.igem.org/Team:Dundee/policypractice/experts">2014 Dundee </a></li>
 
<li><a href="https://2014.igem.org/Team:UC_Davis/Policy_Practices_Overview">2014 UC Davis </a></li>
 
<li><a href="https://2013.igem.org/Team:Manchester/HumanPractices">2013 Manchester </a></li>
 
<li><a href="https://2013.igem.org/Team:Cornell/outreach">2013 Cornell </a></li>
 
</ul>
 
</div>
 
 
 
 
</html>
 

Latest revision as of 03:05, 18 October 2016

Human Practices



Insight on the application of a blood test using the GPC1 detection system


iGEM team members met with an internal medicine specialist, Bibi Zainul, MD., and discussed our project idea as well as applications, should our project succeed. We spoke about the viability of using our yeast as a non-invasive detection tool by performing periodic blood tests on patients who are more susceptible to pancreatic cancer. She made us aware that the tools we require to perform such a test, like a centrifuge and UV lights, are not typically available in most private practice offices and only in some hospitals. She also offered us advice on how to move forward and led us to redesign the application of our project. Due to this, we decided that it would be best to use our project as a lab test that a doctor could order and could be performed off-premises. This affects our project in the following ways:

  • Despite going through an intermediate service, reproducible yeast should still be a cheap alternative to current methods of early detection.
  • We would have to optimize our test to make it more friendly to a hospital environment if we were to try to make it a test that could be done in the hospital.